Imunon, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €1.33B
    R&D expenses
    €1.06B
    EBITDA
    -€2.39B
    D&A
    €474.01K
    EBIT
    -€2.39B
    Interest expenses
    €0.00
    EBT
    -€2.36B
    Tax expenses
    €0.00
    Net income
    -€2.36B

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €304.45M
    Changes in working capital
    -€234.76K
    Operating cash flow
    -€4.98B
    Capex
    €237.67M
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€237.67M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €2.55B
    Debt repayment
    €0.00
    Other financing cash flow
    €4.23B
    Net financing cash flow
    €4.24B
    Foreign exchange effects
    €0.00
    Net change in cash
    €4.05B
    Cash at end of period
    €4.06B
    Free cash flow
    -€4.74B

    Balance sheet

    Cash and cash equivalents
    €0.00
    Cash and short-term investments
    €0.00
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €0.00
    Total current assets
    €0.00
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €0.00
    Accounts payable
    €1.49B
    Short-term debt
    €327.94M
    Other current liabilities
    €2.75B
    Total current liabilities
    €4.56B
    Long-term debt
    €696.00M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €696.00M
    Total liabilities
    €5.26B
    Common stock
    €14.74M
    Retained earnings
    -€354.91B
    Other equity
    €0.00
    Total equity
    €2.28B
    Total liabilities and shareholders' equity
    €7.54B

    Company information

    Market capitalization
    €11.16M
    Employees
    25
    Enterprise Value
    €27.26M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -103.5% Much better than peer group: -576.8%
    ROA
    0.0%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -46,770.4%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€94.50M

    Notifications